Compounds > hydroxyindoleacetic acid

hydroxyindoleacetic acid and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

hydroxyindoleacetic acid has been researched along with 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessandri, MG; Corsini, GU; Fornai, F; Saginario, A; Vaglini, F1
Block, F; Clement, HW; Grote, C; Sontag, KH; Wesemann, W1
Gerlach, M; Przuntek, H; Riederer, P; Russ, H; Stasch, JP; Traber, J; Winker, J; Witzmann, K1
Altagracia, M; Kravzov, J; Rios, C; Rojas, P1
Andrews, AM; Mazzola-Pomietto, P; Murphy, DL; Unger, EL1

Other Studies

5 other study(ies) available for hydroxyindoleacetic acid and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

ArticleYear
beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
    Brain research, 1993, Mar-05, Volume: 605, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Biogenic Monoamines; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Neural Pathways; Nitriles; Rats; Rats, Sprague-Dawley; Species Specificity

1993
Functional studies on monoaminergic transmitter release in parkinsonism.
    Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Monoamines; Dopamine; Dopamine Agents; Dopamine Antagonists; Hydroxyindoleacetic Acid; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Rats; Rats, Wistar; Stereotyped Behavior; Tryptophan

1993
Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Caudate Nucleus; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Nimodipine; Serotonin

1993
Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Proceedings of the Western Pharmacology Society, 1993, Volume: 36

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Parkinson Disease, Secondary; Probenecid; Serotonin

1993
2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Body Temperature; Brain Chemistry; Carrier Proteins; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins

2002